Feb 4, 2025, 16:09
Hidehito Horinouchi: Enhancing performance of automatic trial matching tools in molecular tumor boards
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X about a recent paper by Lilia Gueguen et al. published in npj Precision Oncology:
“npj precision oncology.
A prospective pragmatic evaluation of automatic trial matching tools in a molecular tumor board.
Large Language Model on the patients’ molecular reports could enhance the performance.”
By Dr. Lilia Gueguen.”
“A prospective pragmatic evaluation of automatic trial matching tools in a molecular tumor board”
Authors: Lilia Gueguen, Louise Olgiati, Clément Brutti-Mairesse, Alric Sans, Vincent Le Texier and Loic Verlingue.
More posts featuring Hidehito Horinouchi.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 4, 2025, 16:01
Feb 4, 2025, 15:30
Feb 4, 2025, 15:27
Feb 4, 2025, 14:48
Feb 4, 2025, 14:42
Feb 4, 2025, 14:35